Pregnancy Outcomes Following Exposure to Quinolone Antibiotics – a Systematic-Review and Meta-Analysis

@article{Ziv2018PregnancyOF,
  title={Pregnancy Outcomes Following Exposure to Quinolone Antibiotics – a Systematic-Review and Meta-Analysis},
  author={Aviva Ziv and Reem Masarwa and Amichai Perlman and Danny Ziv and Ilan Matok},
  journal={Pharmaceutical Research},
  year={2018},
  volume={35},
  pages={1-9}
}
PurposeQuinolones, and the fluoroquinolones subgroup, are a class of antibiotics commonly used for the treatment of a wide variety of infections. However, their safety profile in pregnant women is controversial. The association between fluoroquinolones and arthropathy was primarily described in immature animals, and only rarely in humans, yet it has led to the restricted use of quinolones during pregnancy. We aimed to assess their safety during pregnancy.MethodsA systematic review and meta… Expand
Pregnancy outcomes following quinolone and fluoroquinolone exposure during pregnancy: A systematic review and meta-analysis.
TLDR
Quinolone, fluoroquinolone and ciprofloxacin exposure were not associated with a significant increase in major malformations and adverse pregnancy outcomes, other than significantly decreased live birth rate and increased elective termination rate which may be the indicators of misperceived teratogenic risk. Expand
Safety of Antimicrobials During Pregnancy: A Systematic Review of Antimicrobials Considered for Treatment and Postexposure Prophylaxis of Plague.
TLDR
Based on limited data, chloramphenicol and doxycycline may be associated with adverse pregnancy or neonatal outcomes; however, more data are needed to confirm these associations. Expand
In utero exposure to antibiotics and risk of congenital malformations: A population-based study.
TLDR
It is found that there is no increased risk of congenital malformations following first trimester in utero exposure to 10 commonly prescribed systemic antibiotics in Denmark, with a high degree of precision. Expand
Therapeutic concentration of ciprofloxacin and transfer across the human term placenta.
TLDR
This is the first study to verify an accumulation of ciprofloxacin in the placenta that may lengthen the duration of fetal exposure, and is an essential element of fetal risk assessment. Expand
Use of medications during pregnancy and breastfeeding for Crohn’s disease and ulcerative colitis
TLDR
There is reasonable evidence to support the safety of anti-TNF monotherapy and combination therapy during pregnancy and lactation, and Vedolizumab and ustekinumab are thought to be safe in pregnancy and menstruation, while tofacitinib is generally avoided. Expand
Outcomes of drug exposition during pregnancy: Analysis from a teratology information service.
TLDR
Pregnant women counselled by the authors' TIS take a mean of two drugs, ranging from one to 17, which gives a reassuring aspect of drug exposure in pregnancy but takes into account the outcome at birth only. Expand
Current understanding and treatment of intra‐amniotic infection with Ureaplasma spp.
Considerable evidence has shown that intra‐amniotic infection with Ureaplasma spp. increases the risk of chorioamnionitis and preterm labor. Ureaplasma spp. are among the smallest organisms, andExpand
Pharmacotherapy during pregnancy: An endodontists' perspective.
TLDR
The current evidence on the safety of medications commonly used in endodontics including local anesthetics, analgesics, anxiolytics, and antibiotics are reviewed. Expand
A Practical Approach to Antibiotic Use in Critically Ill Obstetric Patients.
TLDR
This article aims to provide a guide for clinicians to select an adequate empirical antibiotic regimen for the most common severe infections that may affect pregnant individuals. Expand
Transferable Mechanisms of Quinolone Resistance from 1998 Onward
  • J. Ruiz
  • Biology, Medicine
  • Clinical Microbiology Reviews
  • 2019
TLDR
There was an explosion of TMQR descriptions in the middle of the first decade of the 21st century, which definitively changed the epidemiology of quinolone resistance. Expand
...
1
2
...

References

SHOWING 1-10 OF 50 REFERENCES
Pregnancy Outcome Following Gestational Exposure to Fluoroquinolones: a Multicenter Prospective Controlled Study
TLDR
It is concluded that the use of fluoroquinolones during embryogenesis is not associated with an increased risk of major malformations and the higher rate of therapeutic abortions observed in quinolone-exposed women compared to that for their controls may be secondary to the misperception of a major risk related to quinoline use during pregnancy. Expand
Safety of the New Quinolones in Pregnancy
TLDR
The use of the new quinolones during the first trimester of pregnancy does not appear to be associated with an increased risk of malformations or musculoskeletal problems; however, longer follow-up and magnetic resonance imaging of the joints may be warranted to exclude subtle cartilage and bone damage. Expand
The safety of quinolones--a meta-analysis of pregnancy outcomes.
TLDR
The use of quinolones during the first trimester of pregnancy does not appear to represent an increased risk for major malformations recognized after birth, stillbirths, preterm births or low birth weight. Expand
Observational Cohort Study of Pregnancy Outcome after First-Trimester Exposure to Fluoroquinolones
TLDR
Findings support the recommendation to allow fluoroquinolone use in early pregnancy in selected cases and detect an increased risk of spontaneous abortion or major birth defects. Expand
Ciprofloxacin Use in Neonates: A Systematic Review of the Literature
TLDR
The current literature provides some information to support the use of ciprofloxacin in neonates, and additional high quality studies should be undertaken to provide reliable data on pharmacokinetics, efficacy, and long-term safety. Expand
Birth outcome following maternal use of fluoroquinolones.
TLDR
It is suggested that the use of fluoroquinolones during pregnancy may not be a major risk factor to the foetus. Expand
Use of antibiotics during pregnancy and risk of spontaneous abortion
TLDR
Use of macro-lides (excluding erythromycin), quinolones, tetracyclines, sulfonamides and metronidazole during early pregnancy was associated with an increased risk of spontaneous abortion. Expand
The Safety of Quinolones in Pregnancy
TLDR
The mechanisms of action of the quinolones and fluoroquinolones are explored, which set the stage for concerns regarding possible teratogenic and mutagenic effects, to clarify the clinical dilemmas that brought forth the necessity in reevaluating the use of those medications during pregnancy and to review the accumulated data regarding their safety during pregnancy in animal models and humans. Expand
Ciprofloxacin safety in paediatrics: a systematic review
TLDR
Musculoskeletal AEs occur due to ciprofloxacin use, however, these musculoskletal events are reversible with management and it is recommended that further prospective controlled studies should be carried out to evaluate the safety of ciproskeletal events, with particular focus on the risk of arthropathy. Expand
Further analysis of the risk of adverse birth outcome after maternal use of fluoroquinolones.
TLDR
The study raises the concern that prenatal fluoroquinolone exposure may be associated with an increased risk of bone malformations. Expand
...
1
2
3
4
5
...